Atorvastatin vs Durvalumab

## Atorvastatin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Atorvastatin** and **Durvalumab**.

## Mechanism of Action

**Atorvastatin**: Competitive inhibitor of HMG-CoA reductase.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Atorvastatin — 14 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Atorvastatin — C33H35FN2O5; Durvalumab — N/A.

**Molecular Weight**: Atorvastatin — 558.6400 g/mol; Durvalumab — N/A.

**Type**: Atorvastatin — Small molecule; Durvalumab — Antibody.